Breaking News Instant updates and real-time market news.

UBSFY

Ubisoft

$0.00

(0.00%)

, NFLX

Netflix

$276.22

8.78 (3.28%)

14:03
10/10/19
10/10
14:03
10/10/19
14:03

Ubisoft planning slate of animated shows based on game series, THR says

Video game publisher Ubisoft (UBSFY), which recently aired the fourth season of its "Rabbids Invasion" show on Netflix (NFLX), is developing even more series based on its video game intellectual properties, the Hollywood Reporter's Patrick Shanley reports. The company's film and TV unit is developing a "Rabbids Invasion" special, as well as other family-friendly shows based on the "Rayman" and "Hungry Shark" franchises, Shanley says. In addition, Ubisoft will tone down its M-rated "Watch Dogs" franchise for a "cybermystery" program aimed at teenagers, the author notes. Meanwhile, the company has partnered with Adi Shankar, who produced Netflix's anime adaptation of game series "Castlevania," for the young-adult series "Captain Laserhawk: A Blood Dragon Vibe," which is based on the Ubisoft game "Far Cry 3: Blood Dragon," the author says. Reference Link

UBSFY

Ubisoft

$0.00

(0.00%)

NFLX

Netflix

$276.22

8.78 (3.28%)

  • 16

    Oct

  • 18

    Oct

  • 29

    Oct

UBSFY Ubisoft
$0.00

(0.00%)

07/15/19
JEFF
07/15/19
UPGRADE
JEFF
Buy
Ubisoft upgraded to Buy from Hold at Jefferies
Jefferies upgraded Ubisoft to Buy from Hold and raised its price target for the shares to 85 euros from 75 euros.
07/29/19
KEYB
07/29/19
INITIATION
KEYB
Overweight
Ubisoft resumed with an Overweight at KeyBanc
KeyBanc analyst Tyler Parker resumed coverage on Ubisoft with an Overweight.
07/30/19
07/30/19
INITIATION

Overweight
KeyBanc bullish on Ubisoft, resumes with an Overweight
As previously reported, KeyBanc analyst Tyler Parker resumed coverage of Ubisoft with an Overweight and EUR94 price target. The analyst believes Ubisoft has executed well in recent history and will continue to benefit from positive industry trends, which should help support growth and margin expansion over at least the next few years.
10/01/19
SPHN
10/01/19
DOWNGRADE
SPHN
Underweight
Ubisoft downgraded to Underweight from Equal Weight at Stephens
Before the open, Stephens analyst Jeff Cohen downgraded Ubisoft to Underweight from Equal Weight and lowered his price target for the shares to 60 euros from 80 euros. The analyst sees "several" near-term headwinds that could cause Ubisoft to miss its fiscal 2020 target for units sold. His retail checks indicate demand for Ghost Recon Breakpoint is below expectations. Cohen also sees the potential for execution risk in fiscal Q4 when Ubisoft has three AAA titles planned in a launch window "with unusually tough competition this year."
NFLX Netflix
$276.22

8.78 (3.28%)

10/09/19
MONN
10/09/19
NO CHANGE
Target $340
MONN
Buy
Netflix price target lowered to $340 from $440 at Monness Crespi
Monness Crespi Hardt analyst Brian White lowered his Q3 revenue estimate for Netflix ahead of next week's report to $5.17B from $5.24B and cut his EPS forecast to $1.00 from $1.03 to account for the weakening macro environment. He also lowered his 2019 and 2020 revenue, EPS and subscriber forecasts, citing macro factors as well as incremental data points around "increasingly fierce competition." White maintains a Buy rating on Netflix shares but lowered his price target on the stock to $340 from $440 to account for his lowered estimates.
10/09/19
RSBL
10/09/19
NO CHANGE
Target $265
RSBL
Neutral
Netflix price target lowered to $265 from $330 at Rosenblatt
Rosenblatt analyst Bernie McTernan said his estimate for Netflix's (NFLX) Q3 subscriber additions is roughly in-line with guidance but he believes the focus of the company's upcoming earnings report will be on the subscriber guidance for Q4, which he thinks "will be treated with greater than normal skepticism" as it will be coming roughly 2 weeks prior to the launch of AppleTV+ (AAPL) and 4 weeks ahead of the launch of Disney+ (DIS). He predicts the heightened competition will lead Netflix to miss the consensus subscriber growth forecast for Q4 and he also sees competition putting upward pressure on content spending, McTernan tells investors. Ahead of the upcoming report, he lowered his price target on Netflix shares to $265 from $330 and keeps a Neutral rating on the stock.
10/10/19
FBCO
10/10/19
NO CHANGE
Target $440
FBCO
Outperform
Credit Suisse expects in line quarterly results for Netflix
Credit Suisse analyst Douglas Mitchelson finds investors are generally expecting a Q3 net adds miss, but his analysis of Sensor Tower first time app download data suggests a strong improvement from Q2 levels, particularly in Europe, and does not clearly point to a miss. The analyst expects in line results and remains comfortable that margins will continue to expand at a healthy pace. Mitchelson has an Outperform rating and $440 price target on the shares.
10/10/19
GSCO
10/10/19
NO CHANGE
Target $360
GSCO
Conviction Buy
Goldman cuts Netflix target to $360 ahead of earnings, but keeps Conviction Buy
Goldman Sachs analyst Heath Terry expects Netflix to report Q3 net subscriber additions that are roughly in-line with the company's previous guidance of 7.0M, but he lowered his price target on the stock $360 from $420 ahead of the company's upcoming report to reflect his revised estimates as well as multiple contraction across the Internet sector. Terry maintains a Buy rating on the stock and keeps it on Goldman's Conviction List, citing his view that a strong Q4 content slate, more stable pricing environment, and high correlation between content additions and subscriber growth will likely drive Q4 results, if not initial guidance, above current consensus. He also notes that the stock is currently trading at nearly a 5-year low on an EV/EBITDA basis.

TODAY'S FREE FLY STORIES

UGAZ

VelocityShares 3x Long Natural Gas ETN

$13.90

0.8 (6.11%)

09:47
10/14/19
10/14
09:47
10/14/19
09:47
Hot Stocks
VelocityShares 3x Long Natural Gas ETN rises 6.1% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$5.71

0.35 (6.53%)

09:47
10/14/19
10/14
09:47
10/14/19
09:47
Hot Stocks
Britannia Bulk rises 6.8% »

Britannia Bulk is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$39.82

2.68 (7.22%)

09:47
10/14/19
10/14
09:47
10/14/19
09:47
Hot Stocks
Aecom rises 7.1% »

Aecom is up 7.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

AYTU

Aytu BioScience

$1.21

(0.00%)

09:42
10/14/19
10/14
09:42
10/14/19
09:42
Conference/Events
Aytu BioScience to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

FCX

Freeport McMoRan

$9.54

(0.00%)

, WDC

Western Digital

$58.36

(0.00%)

09:40
10/14/19
10/14
09:40
10/14/19
09:40
Options
Unusually active option classes on open October 14th »

Unusual total active…

FCX

Freeport McMoRan

$9.54

(0.00%)

WDC

Western Digital

$58.36

(0.00%)

ASHR

X-trackers Harvest CSI 300

$28.16

(0.00%)

BYND

Beyond Meat

$131.40

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

FND

Floor & Decor

$48.93

0.69 (1.43%)

09:39
10/14/19
10/14
09:39
10/14/19
09:39
Recommendations
Floor & Decor analyst commentary  »

Floor & Decor price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

BOX

Box

$16.74

0.345 (2.10%)

09:36
10/14/19
10/14
09:36
10/14/19
09:36
Periodicals
Box hires Morgan Stanley as advisor amid activist push, Dealreporter says »

Faced with activist…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

REPR

RMS Medical Products

$0.00

(0.00%)

09:35
10/14/19
10/14
09:35
10/14/19
09:35
Hot Stocks
RMS Medical Products to commence trading on Nasdaq on October 17 »

Repro Med Systems, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

VRTS

Virtus Investment

$90.90

2.59 (2.93%)

09:34
10/14/19
10/14
09:34
10/14/19
09:34
Upgrade
Virtus Investment rating change  »

Virtus Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNO

Vornado

$62.65

0.46 (0.74%)

09:34
10/14/19
10/14
09:34
10/14/19
09:34
Hot Stocks
Vornado announces certain items to be included in Q3 results »

Vornado Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

CHKP

Check Point

$111.27

1.78 (1.63%)

09:32
10/14/19
10/14
09:32
10/14/19
09:32
Downgrade
Check Point rating change  »

Check Point downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 28

    Oct

  • 16

    Dec

BSMX

Santander Mexico

$6.86

0.165 (2.47%)

09:32
10/14/19
10/14
09:32
10/14/19
09:32
Upgrade
Santander Mexico rating change  »

Santander Mexico upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

09:30
10/14/19
10/14
09:30
10/14/19
09:30
General news
Oil Action: Front-month WIT are down 2.3% »

Oil Action: Front-month…

GM

General Motors

$35.57

0.9 (2.60%)

09:29
10/14/19
10/14
09:29
10/14/19
09:29
Recommendations
General Motors analyst commentary  »

Morgan Stanley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

ACB

Aurora Cannabis

$3.68

-0.045 (-1.21%)

09:28
10/14/19
10/14
09:28
10/14/19
09:28
Recommendations
Aurora Cannabis analyst commentary  »

Aurora Cannabis price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

09:25
10/14/19
10/14
09:25
10/14/19
09:25
General news
Oil Action: Front-month WIT are down 2.3% »

Oil Action: Front-month…

ZLAB

Zai Lab

$32.38

0.01 (0.03%)

09:25
10/14/19
10/14
09:25
10/14/19
09:25
Conference/Events
Zai Lab participates in a conference call with JPMorgan »

SMid Biotechnology Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

09:24
10/14/19
10/14
09:24
10/14/19
09:24
Recommendations
Amazon.com analyst commentary  »

Loop Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

F

Ford

$8.78

0.145 (1.68%)

09:22
10/14/19
10/14
09:22
10/14/19
09:22
Hot Stocks
Ford reports Q3 Europe sales up 3.1% to 313,400 vehicles »

Ford sales grew more than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ACM

Aecom

$37.14

0.35 (0.95%)

, LPG

Dorian LPG

$11.48

0.22 (1.95%)

09:21
10/14/19
10/14
09:21
10/14/19
09:21
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Aecom (ACM), up…

ACM

Aecom

$37.14

0.35 (0.95%)

LPG

Dorian LPG

$11.48

0.22 (1.95%)

LYFT

Lyft

$39.49

1.8 (4.78%)

WDC

Western Digital

$58.36

1.09 (1.90%)

FLXN

Flexion

$13.37

0.125 (0.94%)

AMTD

TD Ameritrade

$35.27

0.78 (2.26%)

IPGP

IPG Photonics

$136.12

6.24 (4.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 30

    Oct

  • 07

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

YNDX

Yandex

$29.95

-5.62 (-15.80%)

09:19
10/14/19
10/14
09:19
10/14/19
09:19
Recommendations
Yandex analyst commentary  »

Foreign ownership limit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

AMCX

AMC Networks

$48.42

0.89 (1.87%)

09:19
10/14/19
10/14
09:19
10/14/19
09:19
Downgrade
AMC Networks rating change  »

Evercore downgrades AMC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/14/19
10/14
09:18
10/14/19
09:18
Options
Overnight activity included 332 trades in SPX and 7 trades in VIX »

332 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$169.06

1.255 (0.75%)

, ABBV

AbbVie

$73.66

1.39 (1.92%)

09:17
10/14/19
10/14
09:17
10/14/19
09:17
Hot Stocks
Allergan shareholders approve AbbVie acquisition proposal »

Allergan (AGN) announced…

AGN

Allergan

$169.06

1.255 (0.75%)

ABBV

AbbVie

$73.66

1.39 (1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TOL

Toll Brothers

$39.49

0.2 (0.51%)

09:16
10/14/19
10/14
09:16
10/14/19
09:16
Downgrade
Toll Brothers rating change  »

Toll Brothers downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.